Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a randomized, phase 3 trial of two different schedules of chemotherapy and radiotherapy for patients with advanced larynx or hypopharynx cancer, no difference was observed in progression-free survival, overall survival, or the maintenance of laryngeal function.

Strategies to Preserve Larynx Function in Patients with Head and Neck Cancer